MediciNova Advances Potential Breakthrough Treatment for Brain Metastasis

La Jolla, Tuesday, 28 April 2026.
A recent study reveals MediciNova’s drug ibudilast successfully suppresses brain metastasis growth, marking a significant clinical advancement in treating one of oncology’s most challenging frontiers.